CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Global stocks in the sweet spot for a reset

Article By: ,  Financial Analyst
  Global stocks in the sweet spot
  • Vindicated by three-week highs across global stocks and most sectors, the advance guard of returning buyers still looked to be in the sweet spot on Friday. Improving sentiment amid de-rated prices was backed by a more contained assessment of geopolitical risks—chiefly Iran-U.S.—continuing ‘goldilocks’ economic conditions and the return of policy divergence versus the Fed. This offered the chance of a global reset following a tough first quarter. The emerging market equity lag of European and U.S. indices that appeared earlier this month was also reversing. The chart below shows large stock markets are returning, or about to return to positive for the year.
  • A mild pullback though, at the time of writing, across U.S. stock index futures, FTSE, DAX and STOXX, was a reminder that the easier dollar scenario taking shape was still equivocal. True, Fed funds futures stalled in the wake of softer U.S. inflation, but not before setting a new cycle peak, like dollar and U.S. benchmark yields over the last 24 hours. The greenback’s pause was pounced on by the bearish cohort of speculators that keeps showing up in CFTC data after an almost three-week advance from April lows. In the case of sterling however, a European close below its 200-day moving average for the first time in over a year is unlikely to be overlooked by momentum-focused dollar bulls. The Kiwi, teetering on the brink of a three-year rising trend line will be similarly tempting. The dollar had been or was turning marginally bid across Sweden’s krona and euro at the time of writing, enough to keep DXY almost a tenth of a percentage point aloft. As such, it’s worth watching the 110 level of the dollar against the yen, after another clear rejection of the psychological barrier overnight. It’s turning into an important inflection point.
  • Oil-sensitive currencies – e.g. a somewhat higher CAD –  should remain attractive under current conditions. Emerging market foreign exchange is another preeminent dollar theatre, particularly with the dam of sovereign bond yields set to stay well and truly burst for some time. The yield on JPMorgan’s EMBI Global has held on to most of its 50-basis point surge of the past few weeks.
  • As such, greenback risks for U.S. shares remain in the spotlight so long as the dollar still looks like it’s embarking on a memorable uptrend. This is less applicable in Europe, where investors continue to make hay whilst ECB patience keeps the euro becalmed. The markets there even appeared more relaxed about a brewing anti-euro coalition in Italy (an announcement is due on Sunday). The same beneficial dynamic fits the FTSE vs. sterling.
  • Oil remains central and it will be interesting on Friday to gauge the strength of shares during a pause for the main futures contracts, even if they were barely lower than the last of a rapid-fire set of new3 ½-year highs.
  • Canada’s monthly employment report could fuel Lonnie momentum against the neighbouring currency, making the release even more worth watching amid a much quieter macroeconomic agenda.
  • Likewise, for stocks, there is now a dearth of the very largest index components on the reporting agenda till next week's Wal-Mart quarterly report. This could mean more attention broad theme of a rebound, though pharma and healthcare shares could see cautious treatment with President Donald Trump set to outline his strategy on lowering prescription drug prices in the U.S.


StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. CFD and Forex Trading are leveraged products and your capital is at risk. They may not be suitable for everyone. Please ensure you fully understand the risks involved by reading our full risk warning.

City Index is a trading name of StoneX Financial Ltd. Head and Registered Office: 1st Floor, Moor House, 120 London Wall, London, EC2Y 5ET. StoneX Financial Ltd is a company registered in England and Wales, number: 05616586. Authorised and regulated by the Financial Conduct Authority. FCA Register Number: 446717.

City Index is a trademark of StoneX Financial Ltd.

The information on this website is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement.

© City Index 2024